This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Achillion Pharmaceuticals Inc (ACHN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 73.66M 33.46M 18.53M 16.11M
Receivables 1.32M 1.78M 277.00K 103.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 387.00K 371.00K 0.00 0.00
Total Current Assets 154.88M 124.78M 67.87M 55.09M
Property, Plant & Equipment, Gross 7.47M 6.70M 6.58M 6.48M
Accumulated Depreciation & Depletion 5.74M 5.44M 5.33M 5.49M
Property, Plant & Equipment, Net 1.73M 1.26M 1.25M 994.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 206.00K 36.37M 12.42M 26.54M
Total Non-Current Assets 1.93M 37.64M 13.66M 27.54M
Liabilities & Shareholder Equity
Total Assets 156.81M 162.42M 81.53M 82.63M
Accounts Payable 6.42M 4.59M 4.28M 4.80M
Short Term Debt 195.00K 291.00K 350.00K 141.00K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 13.06M 9.40M 9.14M 8.94M
Long Term Debt 279.00K 56.00K 347.00K 229.00K
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 2.49M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 279.00K 56.00K 347.00K 2.72M
Total Liabilities 13.34M 9.46M 9.48M 11.66M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 143.47M 152.96M 72.05M 70.97M
Common Par 104.00K 97.00K 80.00K 70.00K
Additional Paid In Capital 599.80M 534.53M 394.68M 346.52M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -450.68M -381.67M -322.73M -275.60M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -5.75M 6.00K 19.00K -20.00K
Total Capitalization 143.75M 153.01M 72.39M 71.20M
Total Equity 143.47M 152.96M 72.05M 70.97M
Total Liabilities & Stock Equity 156.81M 162.42M 81.53M 82.63M
Total Common Shares Outstanding 103.59M 96.79M 79.63M 69.79M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 98.37M 93.98M 73.96M 64.25M
Diluted Weighted Shares Outstanding 98.37M 93.98M 73.96M 64.25M
Number of Employees 67 61 56 48
Number of Part-Time Employees 2 1 1 2
ACHN News

ACHN Achillion Pharmaceuticals Inc

Analysts Ratings for ACHN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 7 8 8
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
GET ACHN ANALYST REPORT

Brokerage Partners

ACHN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs